NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ · Healthcare
NeuroOne Medical Technologies Corporation Operating Income 2020–2025
NeuroOne Medical Technologies Corporation annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- NeuroOne Medical Technologies Corporation operating income for the quarter ending March 31, 2026 was -2.1 M, a 21.61% decrease year-over-year.
- NeuroOne Medical Technologies Corporation operating income for the twelve months ending March 31, 2026 was -7.1 M.
- NeuroOne Medical Technologies Corporation annual operating income for 2025 was -4.2 M, a 64.45% decrease from 2024.
- NeuroOne Medical Technologies Corporation annual operating income for 2024 was -11.9 M, a 0.57% decrease from 2023.
- NeuroOne Medical Technologies Corporation annual operating income for 2023 was -12.0 M, a 19.19% increase from 2022.
- NeuroOne Medical Technologies Corporation annual operating income for 2022 was -10.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NeuroOne Medical Technologies Corporation Operating Income — FAQ
NeuroOne Medical Technologies Corporation (NMTC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is NeuroOne Medical Technologies Corporation's operating income?
NeuroOne Medical Technologies Corporation (NMTC) reported operating income of -$4M for fiscal 2025.
Where can I see NMTC's operating income history?
The chart and table above show NeuroOne Medical Technologies Corporation's operating income by year and by quarter, including the growth rate.